FDA Launches AI-Powered Adverse Event System
The Food and Drug Administration on Tuesday launched the FDA Adverse Event Monitoring System (AEMS), an AI-backed platform that consolidates multiple legacy databases including FAERS and VAERS into a single real-time public portal. The agency said AEMS will process roughly 6–7 million annual reports, yielded a 3,000% pilot user increase, and is expected to save about $120 million over five years.
Scoring Rationale
Major federal deployment modernizes pharmacovigilance and promises cost savings, but reporting completeness and independent validation remain limited.
Practice with real Ad Tech data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Ad Tech problemsStep-by-step roadmaps from zero to job-ready — curated courses, salary data, and the exact learning order that gets you hired.
